Hôpital Maisonneuve-Rosemont
QC, Canada
Explore healthcare research opportunities at a hospital
grant_single_labels|summary
grant_single|eligibleFinancing
- grant_single|noCondition
grant_single|deadlines
- grant_single|openingDateFebruary 08, 2022
grant_single|financingType
Researchers And Facilities
grant_single|eligibleIndustries
- grant_single|allIndustries
grant_single|grantors
- Cognit.ca
- Hôpital Maisonneuve-Rosemont (HMR)
grant_single|status
grant_card_status|open
grant_single_labels|preview
Get access to world-class expertise, facilities and IP when you form a partnership with a university, college or health institution. Use the partnership to help solve complex problems, build proofs-of-concept, improve processes and performance, validate y
grant_single_labels|projects
Hôpital Maisonneuve-Rosemont has been involved in various research projects focused on healthcare innovation and improvements. These projects range from regenerative medicine to public health interventions and advanced training initiatives.
- Elucidating mechanisms of MSC-induced tissue regeneration: path to mesenchymal stromal cell clinical trial in glaucoma.
- Development of the Regenerative Cell Therapy Network (RCTN) focusing on cell therapy innovations.
- Clinical application of a novel molecule that expands human cord blood stem cells.
- Participation in the Canadian National Transplant Research Program to enhance donation and transplantation outcomes.
- Research on personalized cancer immunotherapy to tailor treatments to individual patient needs.
- Investigation of stigma effects on mental health, particularly focusing on the impact on the mentally ill and their families.
- Educational initiatives such as Café Scientifique discussing myths and realities around stem cells.
- Joint team efforts in stem cell technology expansion.
- Public health studies evaluating primary care team effectiveness and health system improvements in Quebec.
- Development of biosynthetic alternatives for human donor corneal transplantation.
- Corneal transplantation studies revisiting traditional surgical paradigms.
grant_single|admissibleProjectsExample
$ 90,000
Design a community-based mental health program with the University of Calgary
$ 175,000
Implement a new electric vehicle charging infrastructure with the University of Waterloo
$ 135,000
Develop biodegradable packaging solutions with McGill University's materials engineering department
$ 150,000
Develop a new AI-driven supply chain management system in collaboration with a university
$ 165,000
Develop an advanced cybersecurity system with the technological institute at the University of Ottawa
$ 225,000
Create a novel healthcare app to monitor chronic diseases with the University of British Columbia
grant_single_labels|admissibility
Eligibility criteria for this grant:
- Applicants must be residents of the specified region.
- Applicants must meet the income requirements.
grant_single_labels|criteria
There are evaluation and selection criteria for this grant. Here is a short summary:
- Submissions will be evaluated based on scientific merit, feasibility, methodology, impact, and alignment with the grant objectives.
- Applicants must demonstrate a clear research plan, strong methodology, feasibility of the project, and the potential impact of the research.
Apply to this program
Operating Grant: Extended prophylaxis comparing low molecular weight heparin (LMWH) to aspirin in total hip arthroplasty (EPCAT study)
Operating Grant: Extended prophylaxis comparing low molecular weight heparin (LMWH) to aspirin in total hip arthroplasty (EPCAT study)
The Operating Grant for the EPCAT study focuses on comparing extended prophylaxis using low molecular weight heparin (LMWH) versus aspirin in total hip arthroplasty. This research project aims to evaluate the effectiveness and safety of these two prophylactic treatments to prevent complications post-surgery, particularly in the context of total hip arthroplasty. Through rigorous clinical trials and data analysis, the study seeks to provide valuable insights that can potentially improve post-surgery care and outcomes for patients undergoing total hip arthroplasty.
